SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Joint Consensus Statement on the Vaccination of Adult and Paediatric Haematopoietic Stem Cell Transplant Recipients. Prepared on Behalf of the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT), the Children's Cancer and Leukaemia Group (CCLG), and British Infection Association (BIA).

Miller, P; Patel, SR; Skinner, R; Dignan, F; Richter, A; Jeffery, K; Khan, A; Heath, PT; Clark, A; Orchard, K; et al. Miller, P; Patel, SR; Skinner, R; Dignan, F; Richter, A; Jeffery, K; Khan, A; Heath, PT; Clark, A; Orchard, K; Snowden, JA; de Silva, TI (2022) Joint Consensus Statement on the Vaccination of Adult and Paediatric Haematopoietic Stem Cell Transplant Recipients. Prepared on Behalf of the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT), the Children's Cancer and Leukaemia Group (CCLG), and British Infection Association (BIA). J Infect, 86 (1). pp. 1-8. ISSN 1532-2742 https://doi.org/10.1016/j.jinf.2022.11.005
SGUL Authors: Heath, Paul Trafford

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (540kB) | Preview
[img] Microsoft Word (.docx) (Supplementary materials) Published Version
Available under License Creative Commons Attribution.

Download (28kB)
[img] Microsoft Word (.docx) (Supplementary materials) Published Version
Available under License Creative Commons Attribution.

Download (28kB)

Abstract

Haematopoietic stem cell transplant (HSCT) recipients have deficiencies in their adaptive immunity against vaccine preventable diseases. National and International guidance recommends that HSCT recipients are considered 'never vaccinated' and offered a comprehensive course of revaccination. This position statement aims to draw upon the current evidence base and existing guidelines, and align this with national vaccine availability and licensing considerations in order to recommend a pragmatic and standardised re-vaccination schedule for adult and paediatric HSCT recipients in the UK.

Item Type: Article
Additional Information: © 2022 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
Keywords: haematopoietic stem cell transplant, immunisation, vaccination, 1103 Clinical Sciences, Microbiology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: J Infect
ISSN: 1532-2742
Language: eng
Dates:
DateEvent
24 December 2022Published
15 November 2022Published Online
10 November 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 36400155
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115014
Publisher's version: https://doi.org/10.1016/j.jinf.2022.11.005

Actions (login required)

Edit Item Edit Item